Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-25-000500
Filing Date
2025-01-28
Accepted
2025-01-28 11:26:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 9114
  Complete submission text file 0000902664-25-000500.txt   10787
Mailing Address 475 TENTH AVENUE, 14TH FLOOR NEW YORK NY 10018
Business Address 475 TENTH AVENUE, 14TH FLOOR NEW YORK NY 10018 646-216-7040
12 West Capital Management LP (Filed by) CIK: 0001540531 (see all company filings)

IRS No.: 453076594 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 (858) 546-0004
MARAVAI LIFESCIENCES HOLDINGS, INC. (Subject) CIK: 0001823239 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92094 | Film No.: 25561989
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)